Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Anemia, Diamond-Blackfan

ClinicalTrials.gov lists 56 trials for Anemia, Diamond-Blackfan or a narrower condition beneath it.

MeSH D029503 Hemic and Lymphatic Diseases C15 C16 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 5 Phase 1/2 Phase 1/2 12 Phase 2 Phase 2 18 Phase 2/3 Phase 2/3 2 Phase 3 Phase 3 2 Phase 4 Phase 4 1 Not applicable Not applicable 7 Observational Observational 9 Phase 1 Phase 1 5 Phase 1/2 Phase 1/2 12 Phase 2 Phase 2 18 Phase 2/3 Phase 2/3 2 Phase 3 Phase 3 2 Phase 4 Phase 4 1 Not applicable Not applicable 7 Observational Observational 9

Trials per phase

56 of the 56 trials are tagged with Anemia, Diamond-Blackfan itself; the rest are tagged with a narrower condition beneath it.

Get the Anemia, Diamond-Blackfan report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Anemia, Diamond-Blackfan trials start? (26)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 5

1994: 1 trials (Phase 2 1) 1995: 1 trials (Not applicable 1) 1998: 1 trials (Phase 2 1) 1999: 2 trials (Not applicable 1, Phase 2 1) 2000: 3 trials (Not applicable 1, Phase 2/3 1, Phase 1/2 1) 2001: 2 trials (Observational 1, Phase 2 1) 2002: 1 trials (Phase 2/3 1) 2003: 2 trials (Phase 2 2) 2005: 5 trials (Not applicable 1, Phase 3 2, Phase 2 2) 2007: 3 trials (Phase 4 1, Phase 2 2) 2008: 1 trials (Phase 1 1) 2009: 3 trials (Observational 1, Phase 2 2) 2010: 2 trials (Observational 1, Not applicable 1) 2011: 1 trials (Phase 1/2 1) 2012: 3 trials (Not applicable 1, Phase 2 1, Phase 1/2 1) 2013: 4 trials (Phase 1/2 3, Phase 1 1) 2014: 5 trials (Not applicable 1, Phase 2 2, Phase 1/2 1, Phase 1 1) 2015: 1 trials (Phase 1 1) 2016: 1 trials (Observational 1) 2017: 4 trials (Observational 2, Phase 2 1, Phase 1/2 1) 2018: 2 trials (Phase 1/2 2) 2019: 1 trials (Phase 1/2 1) 2020: 2 trials (Observational 1, Phase 1/2 1) 2021: 1 trials (Phase 2 1) 2022: 2 trials (Observational 1, Phase 2 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 2
2022 2
2021 1
2020 2
2019 1
2018 2
2017 4
2016 1
2015 1
2014 5

No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Anemia, Diamond-Blackfan trials in? (8)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 5
Phase 1/2 12
Phase 2 18
Phase 2/3 2
Phase 3 2
Phase 4 1
Not applicable 7
Observational 9

How many Anemia, Diamond-Blackfan trials are recruiting? (6)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 10
Active, not recruiting 1
Completed 31
Terminated 11
Withdrawn 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Anemia, Diamond-Blackfan trials? (4)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
National Heart, Lung, and Blood Institute (NHLBI) 5
Novartis Pharmaceuticals 5
Bellicum Pharmaceuticals 3
Apriligen, Inc. 1

Which drugs are being tested for Anemia, Diamond-Blackfan? (3)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Busulfan 6
Cytoxan 4
Melphalan 4

Interventions as named in the registry (12)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
SQ Fludarabine 10
Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)] 7
Peripheral blood stem cell transplantation 6
Deferasirox FCT 6
Allogeneic bone marrow transplantation 4

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Anemia, Diamond-Blackfan trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Pyrexia 28 5
Sickle cell anaemia with crisis 27 1
Infection 15 4
Acute graft versus host disease 12 2
Sepsis 11 6

Which publications cover Anemia, Diamond-Blackfan? (57)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Prevalence (18)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Diamond-Blackfan anemia Prevalence at birth 1-9 / 1 000 000 United Kingdom GB Unspecified
Diamond-Blackfan anemia Prevalence at birth 1-9 / 1 000 000 United Kingdom GB Exact
Diamond-Blackfan anemia Prevalence at birth 1-9 / 1 000 000 United Kingdom GB Exact
Diamond-Blackfan anemia Prevalence at birth 1-9 / 1 000 000 United States US Exact
Diamond-Blackfan anemia Prevalence at birth 1-9 / 1 000 000 United States US Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Diamond-Blackfan anemia 124 Exact Orphadata Science knowledge files, Product 1
Diamond-Blackfan anemia 124 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: sub-conditions in mesh.

Browse all condition evidence pages